Renewvax.com



info@renewvax.com

  • Follow
  • Follow
  • Corporate
  • Business Plan
  • News
  • Privacy Policy
  • Corporate
  • Business Plan
  • News
  • Privacy Policy
  • RVX-001
  • RVX-002
  • RVX-003
ReNewVax Ltd will make a stop at BIO-Europe in Leipzig, Germany

ReNewVax Ltd will make a stop at BIO-Europe in Leipzig, Germany

by renewvax-admin | Jul 17, 2022 | News

ReNewVax will attend BIO-Europe in Leipzig, Germany on October 24th-26th, 2022. The event is expected to gather over 4,000+ global biopharma executives. We will be particularly focussed on the themes Respiratory and Infectious diseases, Immune profiling, Vaccine...
ReNewVax Ltd. selected as one of the start-up companies to exhibit at the World Vaccine Congress Europe 2022

ReNewVax Ltd. selected as one of the start-up companies to exhibit at the World Vaccine Congress Europe 2022

by renewvax-admin | Jun 30, 2022 | News

ReNewVax was selected as one of the start-ups companies that will exhibit at the World Vaccine Congress Europe in Barcelona, on 11-14th October 2022. We look forward to presenting our lead vaccine programme and would be happy to talk with partners or investors who are...
ReNewVax Ltd. attended ISPPD-2022 on 19-23 June 2022 in Toronto, Canada.

ReNewVax Ltd. attended ISPPD-2022 on 19-23 June 2022 in Toronto, Canada.

by renewvax-admin | Jun 17, 2022 | News

ReNewVax attended the 12th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD), which took place in Toronto, Canada on 19-23 June 2022. The event was attended by over 1,000 delegates from around the globe, and included researchers, clinicians,...
Next Entries »

Recent Posts

  • ReNewVax named ‘One to Watch’ in UKTN’s guide to University Spinouts
  • Drug Target Review publishes in-depth focus on ReNewVax
  • ReNewVax’s leadership team reflect on the company’s first year
  • ReNewVax featured in July’s European Pharmaceutical Review
  • North West Business Insider names ReNewVax as one of the region’s most exciting companies

About Us

ReNewVax Ltd. is a University of Liverpool spin-out company co-founded by Dr Marie Yang and Prof Aras Kadioglu. The company was created through seed funding from the University of Liverpool’s Enterprise Investment Fund and Innovate UK.

Links

  • Corporate
  • Business Plan
  • News
  • Privacy Policy

Pipeline

  • RVX-001
  • RVX-002
  • RVX-003

Contact



Email

info@renewvax.com

©ReNewVax Ltd | All Rights Reserved

  • Follow
  • Follow